Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12 vs 20 Weeks Steroid Therapy for First Episode Nephrotic Syndrome
NCT04713410Unknown
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone in nephrotic syndrome (2 arms), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoint: Relapse rate at 2 years. Status: unknown.
02
Drugs
prednisolone
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT04713410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04713410.